Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

36P - Young breast cancer biology explored by NanoString BC360 panel in a formalin-fixed paraffin-embedded cohort

Date

04 May 2022

Session

Poster Display session

Topics

Translational Research

Tumour Site

Breast Cancer

Presenters

Lise Martine Ingebriktsen

Citation

Annals of Oncology (2022) 33 (suppl_3): S123-S147. 10.1016/annonc/annonc888

Authors

L.M. Ingebriktsen1, A.A. Svanøe1, A.K.M. Sæle1, K. Toska1, M.B. Kalvenes1, B. Davidsen1, A. Heie1, G. Knutsvik1, I.M. Stefansson1, L.A. Akslen1, E. Wik2

Author affiliations

  • 1 University of Bergen, Bergen/NO
  • 2 University of Bergen, 5020 - Bergen/NO

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 36P

Background

Platforms that enable multiplexed analysis of biomarkers from limited amounts of poor-quality material provide value to studies of archival tissue material. The NanoString nCounter® technology allows nonamplified measurements of up to 800 targets within one sample of archived formalin fixed paraffin embedded (FFPE) material. We aimed to compare gene expression in young vs old breast cancer (BC) patients, using archived FFPE material to gain insight into BC biology of the young.

Methods

The NanoString BC360 panel was explored by NanoString nCounter® to investigate gene expression in an in-house BC FFPE archive cohort (diagnosed 1996-2003; age <50 years at diagnosis; n= 129). Data were analysed in nSolver and ROSALIND. Protein-protein interaction (PPI) networks were explored. The Cancer Genome Atlas global gene expression BC data (n=520) was analyzed for validation.

Results

We identified 58 differentially expressed genes (DEGs) in BC samples from young (aged <40) and older patients. In PPI networks, representing the DEGs, we identified highly interconnected regions (sub-clusters), pointing to DEGs indicating increased immune infiltration and inflammatory mechanisms, as well as oncogenic signaling favoring tumor promotion, in BC of the young. Validation in TCGA BC data demonstrated gene expression patterns reflecting overall increased T-cell activation and higher levels of T regulatory immune cells and PD-1 in BC of the young (P<0.04).

Conclusions

The current study indicates increased immune cell activation supporting an immune evasive environment in young BC. Also, higher oncogenic signaling in this patient subset supports increased tumor-promoting processes.

Legal entity responsible for the study

The authors.

Funding

Helse Vest and University of Bergen.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.